Dublin, Feb. 15, 2024 (GLOBE NEWSWIRE) — The “Bone Growth Stimulators – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
Global Bone Growth Stimulators Market to Reach $1.5 Billion by 2030
The global market for Bone Growth Stimulators estimated at US$1.1 Billion in the year 2022, is projected to reach a revised size of US$1.5 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2022-2030. Stimulation Devices, one of the segments analyzed in the report, is projected to record 4.8% CAGR and reach US$855.7 Million by the end of the analysis period. Growth in the Bone Morphogenetic Proteins (bmp) segment is estimated at 4.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $544 Million, While China is Forecast to Grow at 6.6% CAGR
The Bone Growth Stimulators market in the U.S. is estimated at US$544 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$109.1 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.
What`s New?
- Special discussions on the global economic climate and market sentiment
- Coverage on global competitiveness and key competitor percentage market shares
- Market presence analysis across multiple geographies – Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and trademarked research platform
- Complimentary updates for one year
- Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Key Attributes:
Report Attribute | Details |
No. of Pages | 492 |
Forecast Period | 2022 – 2030 |
Estimated Market Value (USD) in 2022 | $1.1 Billion |
Forecasted Market Value (USD) by 2030 | $1.5 Billion |
Compound Annual Growth Rate | 4.0% |
Regions Covered | Global |
MARKET OVERVIEW
- Bone Growth Stimulators – Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- COVID-19 Casts Shadow over Normalcy of Orthopedic Surgery Volumes
- Number of Elective Orthopaedic Surgical Procedures Conducted in the US: April-June 2020 Vs April-June 2019
- Pandemic Scare Helps Hospitals Shift Gears from In-patient to Out-patient Surgeries
- Bone Growth Stimulator: A Prelude
- Types of Bone Growth Stimulators
- Market Overview and Outlook
- Hospitals & Clinics: Primary End-User Segment
- US Holds Predominance in Global Bone Growth Stimulators Market
- US FDA Proposes Down-Classification of Non-Invasive Bone Growth Stimulators
- Competition
- Market Share of Leading Players in Global Bone Growth Stimulators Market: 2019
- Recent Market Activity
MARKET TRENDS & DRIVERS
- Increase in Number of Fractures and Rise in incidence of Delayed Union & Nonunion Bone Fractures Elevates Demand for Bone Stimulators
- Osteoporosis and Other Bone Related Health Concerns: Factsheet
- Hip Fracture Stats
- Select Musculoskeletal Conditions – Percentage Breakdown by Age Group
- Percentage Share Breakdown of Number of Fractures by Age Group: 2019
- Rise in Vertebral Fractures to Steer Growth
- Vertebral Fracture Stats
- Increasing Cases of Trauma Underpins Demand
- Rise in Incidence Osteoporosis to Benefit Market Growth
- Global Osteoporosis Prevalence: Number of People with Osteoporosis in Millions by Select Country/Region for 2012 and 2022P
- Spinal Fusion Surgery Holds Strong Opportunities
- US Spinal Fusion Surgery Market: Percentage Breakdown of Procedure Volume by Age Group
- Bone Stimulators Display Potential for Application in Treatment of Osteoarthritis
- Role of Platelet-Rich Plasma (PRP) as Bone Growth Stimulants
- Rise in Minimally Invasive Surgeries and Robotic Surgeries to Boost Prospects
- World Surgical Robots Market by Surgery Type: 2019
- Technology Advancements in Implants Drive Surgery Volumes, Supporting the demand for Bone Stimulators
- Demographic Factors Buoying Growth
- Epidemic Proportion of Obesity
- Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025
- Average Per Capita Annual Health Expenditure (In US$) due to Obesity
- Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
- Alarming Levels of Diabetes Incidence and Increased Risk of Impaired Fracture Healing to Benefit Demand
- World Diabetes and Population Statistics (2019, 2030 & 2045)
- World Diabetes Prevalence (2000-2045P)
- Aging Population and their Vulnerability to Various Bone and Joint Related Diseases and Disorders Drive Healthy Market Growth
- Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
- TABLE 19: Global Life Expectancy at Birth (Years) by Geographic Region: 1950-2050
- Rise in Healthcare Expenditure to Drive Growth
- World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
FOCUS ON SELECT PLAYERS(Total 62 Featured)
- AIDP, Inc.
- Bioiberica SAU
- Douglas Laboratories
- Bioventus LLC
- DePuy Synthes
- Hellenia Ltd.
- Isto Biologics
- Dr. PRP America LLC
- EmCyte Corporation
- Innophos, Inc.
- Amway, Inc. – Nutrilite
- G&G Vitamins
- Isotonix
- Cellumed Co., Ltd.
- Glofinn Oy
For more information about this report visit https://www.researchandmarkets.com/r/8nt6ne
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Bone Growth Stimulators Market